Skip to main content
Erschienen in: Pediatric Nephrology 11/2007

01.11.2007 | Original Article

Selective late steroid withdrawal after renal transplantation

verfasst von: Guido F. Laube, Jutta Falger, Markus J. Kemper, Andrea Zingg-Schenk, Thomas J. Neuhaus

Erschienen in: Pediatric Nephrology | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Steroid withdrawal (SW) after paediatric renal transplantation (RTPL) is controversial. Selective late SW has been performed in our unit since 1995. The safety and effects of SW were analysed retrospectively in 47 patients undergoing RTPL between 1995 and 2004. Initial immunosuppression consisted of cyclosporine A, azathioprine or mycophenolate mofetil and steroids. Criteria for SW were: (1) stable renal function, (2) time interval after RTPL ≥ 1 year, (3) no rejection or time interval after last rejection ≥ 1 year and (4) good compliance. SW was performed in 30 patients at an age of 13.5 years (range 4.5–18.5) and 2.2 years (range 1–6.6) after RTPL. After SW, one patient experienced a steroid-sensitive rejection. Follow-up after SW (1.3 year; range 0.25–7.5) showed maintained renal function: glomerular filtration rate at SW and currently was 82 (65–128) and 82 (42–115) ml/min per 1.73 m2, respectively. The number of patients on antihypertensive treatment did not significantly change (at SW: n = 15; currently: n = 11). Height and body mass index (BMI) remained stable: Median standard deviation score (SDS) for height/BMI at SW and currently was −1.1/0.2 and −0.8/0.1, respectively. Selective late SW was safe regarding renal function and had no significant effect on blood pressure and growth.
Literatur
1.
Zurück zum Zitat Tonshoff B, Mehls O (1997) Factors affecting growth and strategies for treatment in children after renal transplantation. Pediatr Transplant 1:176–182PubMed Tonshoff B, Mehls O (1997) Factors affecting growth and strategies for treatment in children after renal transplantation. Pediatr Transplant 1:176–182PubMed
2.
Zurück zum Zitat Acott PD, Crocker JF, Wong JA (2003) Decreased bone mineral density in the pediatric renal transplant population. Pediatr Transplant 7:358–363CrossRef Acott PD, Crocker JF, Wong JA (2003) Decreased bone mineral density in the pediatric renal transplant population. Pediatr Transplant 7:358–363CrossRef
3.
Zurück zum Zitat Vidhun JR, Sarwal MM (2005) Corticosteroid avoidance in pediatric renal transplantation. Pediatr Nephrol 20:418–426CrossRef Vidhun JR, Sarwal MM (2005) Corticosteroid avoidance in pediatric renal transplantation. Pediatr Nephrol 20:418–426CrossRef
4.
Zurück zum Zitat Oberholzer J, John E, Lumpaopong A, Testa G, Sankary HN, Briars L, Kraft KA, Knight PS, Verghese P, Benedetti E (2005) Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients. Pediatr Transplant 9:456–463CrossRef Oberholzer J, John E, Lumpaopong A, Testa G, Sankary HN, Briars L, Kraft KA, Knight PS, Verghese P, Benedetti E (2005) Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients. Pediatr Transplant 9:456–463CrossRef
5.
Zurück zum Zitat Ellis D (2000) Growth and renal function after steroid-free tacrolimus-based immunosuppression in children with renal transplants. Pediatr Nephrol 14:689–694CrossRef Ellis D (2000) Growth and renal function after steroid-free tacrolimus-based immunosuppression in children with renal transplants. Pediatr Nephrol 14:689–694CrossRef
6.
Zurück zum Zitat Motoyama O, Hasegawa A, Ohara T, Satoh M, Shishido S, Honda M, Tsuzuki K, Kinukawa T, Hattori M, Ito K, Ogawa O, Yanagihara T, Saito K, Takahashi K, Ohshima S (2005) A prospective trial of steroid withdrawal after renal transplantation treated with cyclosporine and mizoribine in children: results obtained between 1990 and 2003. Pediatr Transplant 9:232–238CrossRef Motoyama O, Hasegawa A, Ohara T, Satoh M, Shishido S, Honda M, Tsuzuki K, Kinukawa T, Hattori M, Ito K, Ogawa O, Yanagihara T, Saito K, Takahashi K, Ohshima S (2005) A prospective trial of steroid withdrawal after renal transplantation treated with cyclosporine and mizoribine in children: results obtained between 1990 and 2003. Pediatr Transplant 9:232–238CrossRef
7.
Zurück zum Zitat Chakrabarti P, Wong HY, Scantlebury VP, Jordan ML, Vivas C, Ellis D, Lombardozzi-Lane S, Hakala TR, Fung JJ, Simmons RL, Starzl TE, Shapiro R (2000) Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 70:760–764CrossRef Chakrabarti P, Wong HY, Scantlebury VP, Jordan ML, Vivas C, Ellis D, Lombardozzi-Lane S, Hakala TR, Fung JJ, Simmons RL, Starzl TE, Shapiro R (2000) Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 70:760–764CrossRef
8.
Zurück zum Zitat Jensen S, Jackson EC, Riley L, Reddy S, Goebel J (2003) Tacrolimus-based immunosuppression with steroid withdrawal in pediatric kidney transplantation-4-year experience at a moderate-volume center. Pediatr Transplant 7:119–124CrossRef Jensen S, Jackson EC, Riley L, Reddy S, Goebel J (2003) Tacrolimus-based immunosuppression with steroid withdrawal in pediatric kidney transplantation-4-year experience at a moderate-volume center. Pediatr Transplant 7:119–124CrossRef
9.
Zurück zum Zitat Hocker B, John U, Plank C, Wuhl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tonshoff B (2004) Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years. Transplantation 78:228–234CrossRef Hocker B, John U, Plank C, Wuhl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tonshoff B (2004) Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years. Transplantation 78:228–234CrossRef
10.
Zurück zum Zitat Silverstein DM, Aviles DH, LeBlanc PM, Jung FF, Vehaskari VM (2005) Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients. Pediatr Transplant 9:589–597CrossRef Silverstein DM, Aviles DH, LeBlanc PM, Jung FF, Vehaskari VM (2005) Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients. Pediatr Transplant 9:589–597CrossRef
11.
Zurück zum Zitat Sarwal MM, Yorgin PD, Alexander S, Millan MT, Belson A, Belanger N, Granucci L, Major C, Costaglio C, Sanchez J, Orlandi P, Salvatierra O Jr (2001) Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 72:13–21CrossRef Sarwal MM, Yorgin PD, Alexander S, Millan MT, Belson A, Belanger N, Granucci L, Major C, Costaglio C, Sanchez J, Orlandi P, Salvatierra O Jr (2001) Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 72:13–21CrossRef
12.
Zurück zum Zitat Pascual J, Quereda C, Zamora J, Hernandez D (2005) Updated metaanalysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil. Transplant Proc 37:3746–3748CrossRef Pascual J, Quereda C, Zamora J, Hernandez D (2005) Updated metaanalysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil. Transplant Proc 37:3746–3748CrossRef
13.
Zurück zum Zitat Klaus G, Jeck N, Konrad M, Forster B, Soergel M (2001) Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity. Clin Nephrol 56:S37–S42PubMed Klaus G, Jeck N, Konrad M, Forster B, Soergel M (2001) Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity. Clin Nephrol 56:S37–S42PubMed
14.
Zurück zum Zitat Sarwal M (2006) Steroid elimination is coming of age. Pediatr Nephrol 21:2–4CrossRef Sarwal M (2006) Steroid elimination is coming of age. Pediatr Nephrol 21:2–4CrossRef
15.
Zurück zum Zitat Marks SD, Trompeter RS (2006) Steroid preservation: the rationale for continued prescribing. Pediatr Nephrol 21:305–307CrossRef Marks SD, Trompeter RS (2006) Steroid preservation: the rationale for continued prescribing. Pediatr Nephrol 21:305–307CrossRef
16.
Zurück zum Zitat Tönshoff B, Offner G, Hoecker B, Pape L, Rascher W, Neuhaus T, Hoppe B, Querfeld U, Bulla M, Klaus G, Latta K, Leichter H, Fehrenbach H, Wygoda S, Misselwitz J, Montoya C, Mueller-Wiefel D, Foulard M, Hoyer P, Cochat P, Fischer W, Zimmerhackl LB (2006) A multicenter, placebo-controlled trial evaluating the efficacy and safety of Basiliximab (Simulect) in combination with CsA, MMF and steroids in pediatric renal allograft recipients: 12 months results. Pediatr Nephrol 21:1513 (abstract) Tönshoff B, Offner G, Hoecker B, Pape L, Rascher W, Neuhaus T, Hoppe B, Querfeld U, Bulla M, Klaus G, Latta K, Leichter H, Fehrenbach H, Wygoda S, Misselwitz J, Montoya C, Mueller-Wiefel D, Foulard M, Hoyer P, Cochat P, Fischer W, Zimmerhackl LB (2006) A multicenter, placebo-controlled trial evaluating the efficacy and safety of Basiliximab (Simulect) in combination with CsA, MMF and steroids in pediatric renal allograft recipients: 12 months results. Pediatr Nephrol 21:1513 (abstract)
17.
Zurück zum Zitat Chantler C, Barratt TM (1972) Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid. Arch Dis Child 47:613–617CrossRef Chantler C, Barratt TM (1972) Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid. Arch Dis Child 47:613–617CrossRef
18.
Zurück zum Zitat National High Blood Pressure Education Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 (2 Suppl):555–576 National High Blood Pressure Education Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 (2 Suppl):555–576
19.
Zurück zum Zitat Mitsnefes MM, Khoury PR, McErny PT (2003) Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr 143:98–103CrossRef Mitsnefes MM, Khoury PR, McErny PT (2003) Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr 143:98–103CrossRef
20.
Zurück zum Zitat Prader A, Largo RH, Molinari L, Issler C (1989) Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 52:1–125PubMed Prader A, Largo RH, Molinari L, Issler C (1989) Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 52:1–125PubMed
21.
Zurück zum Zitat Cattaneo D, Perico N, Gaspari F, Gotti E, Remuzzi G (2002) Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation. Kidney Int 62:1060–1067CrossRef Cattaneo D, Perico N, Gaspari F, Gotti E, Remuzzi G (2002) Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation. Kidney Int 62:1060–1067CrossRef
22.
Zurück zum Zitat Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K (2005) Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 80:1233–1243CrossRef Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K (2005) Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 80:1233–1243CrossRef
23.
Zurück zum Zitat Mitsnefes MM (2004) Hypertension and end-organ damage in pediatric renal transplantation. Pediatr Transplant 8:394–399CrossRef Mitsnefes MM (2004) Hypertension and end-organ damage in pediatric renal transplantation. Pediatr Transplant 8:394–399CrossRef
24.
Zurück zum Zitat El-Husseini AA, Foda MA, Shokeir AA, Shehab El-Din AB, Sobh MA, Ghoneim MA (2005) Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience. Pediatr Transplant 9:763–769CrossRef El-Husseini AA, Foda MA, Shokeir AA, Shehab El-Din AB, Sobh MA, Ghoneim MA (2005) Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience. Pediatr Transplant 9:763–769CrossRef
25.
Zurück zum Zitat Watson AR (2000) Non-compliance and transfer from paediatric to adult transplant unit. Pediatr Nephrol 14:469–472CrossRef Watson AR (2000) Non-compliance and transfer from paediatric to adult transplant unit. Pediatr Nephrol 14:469–472CrossRef
26.
Zurück zum Zitat Neu AM (2006) Special issues in pediatric kidney transplantation. Adv Chronic Kidney Dis 13:62–69CrossRef Neu AM (2006) Special issues in pediatric kidney transplantation. Adv Chronic Kidney Dis 13:62–69CrossRef
Metadaten
Titel
Selective late steroid withdrawal after renal transplantation
verfasst von
Guido F. Laube
Jutta Falger
Markus J. Kemper
Andrea Zingg-Schenk
Thomas J. Neuhaus
Publikationsdatum
01.11.2007
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 11/2007
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-007-0576-1

Weitere Artikel der Ausgabe 11/2007

Pediatric Nephrology 11/2007 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.